Lung Cancer Clinical Trials in Ventura, CA

Lung Cancer Clinical Trials in Ventura, CA

View the best 10 lung cancer medical studies in Ventura, California. Access promising new therapies by applying to a Ventura-based Lung Cancer clinical trial.

Top rated lung cancer clinical trials in Ventura, California

Here are the top 10 medical studies for lung cancer in Ventura, California

Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Pemetrexed +1 More

Anti-metabolites

Recruiting2 awardsPhase 3
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Crizotinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of Yuma Regional Medical Center Cancer Center in Yuma, United States.

Encorafenib +1 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for patients with a specific type of lung cancer. The trial will test how well the new therapy works and if it is safe.
Image of Leonard Cancer Institute in Mission Viejo, United States.

Observation

Recruiting1 award9 criteria
This trial is testing whether post-operative chemotherapy is better than radiographic surveillance for stage I or stage IIA non-small cell lung cancer patients.
Image of VA Long Beach Healthcare System, Long Beach, CA in Long Beach, United States.

Stereotactic Radiotherapy +1 More

Radiation Therapy

Recruiting1 award16 criteria
This trial is testing whether surgery or stereotactic radiotherapy is better for people with stage I non-small cell lung cancer.
Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Amivantamab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug to treat NSCLC, which is the most common type of lung cancer. The purpose of the study is to see if the drug is safe and effective, and to find the best dose.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is designed to study the effects of a new drug, selpercatinib, on various types of solid tumors. The goal is to see if it is safe and tolerable, how it is metabolized, and if it has any preliminary anti-tumor activity.
Image of City of Hope in Duarte, United States.

INBRX-106 +1 More

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 1 & 2
This trial is studying a new drug to see if it is safe and effective at treating locally advanced or metastatic non small cell lung cancer when given in combination with pembrolizumab (Keytruda).

Popular filter options for lung-cancer ventura trials

Phase 3 Clinical Trials

View 99 phase 3 medical studies.

Clinical Trials With No Placebo

View 99 medical studies that do not have a placebo group.

View More Lung-cancer Ventura Trials

See another 84 medical studies focused on lung-cancer ventura.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.